TG THERAPEUTICS, INC. short interest in 2025
In 2025, TG THERAPEUTICS, INC.'s disclosed short interest ran from 17.75% of shares outstanding on 15 Jan 2025 to 16.11% on 31 Dec 2025, a change of -1.64 percentage points. The year's high was 17.75% on 15 Jan 2025 and its low 14.37% on 15 May 2025, averaging 15.61% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.26 days on 31 Dec 2025. Full history: TG THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 17.75% (15 Jan 2025)
- End of year
- 16.11% (31 Dec 2025)
- Change
- -1.64 pp
- High
- 17.75% (15 Jan 2025)
- Low
- 14.37% (15 May 2025)
- Average
- 15.61%
- Highest days to cover
- 18.26 (31 Dec 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 17.75% | 8.54 | |
| 31 Jan 2025 | 17.27% | 12.49 | |
| 14 Feb 2025 | 16.54% | 18.23 | |
| 28 Feb 2025 | 16.52% | 14.41 | |
| 14 Mar 2025 | 16.70% | 5.36 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 15.85% | 10.61 | |
| 15 Apr 2025 | 14.99% | 7.05 | |
| 30 Apr 2025 | 14.72% | 10.51 | |
| 15 May 2025 | 14.37% | 5.72 | results (8-K), 10-Q filed |
| 30 May 2025 | 15.01% | 15.63 | |
| 13 Jun 2025 | 15.09% | 12.78 | |
| 30 Jun 2025 | 15.32% | 14.50 | |
| 15 Jul 2025 | 15.39% | 16.85 | |
| 31 Jul 2025 | 14.92% | 14.64 | |
| 15 Aug 2025 | 14.84% | 6.22 | results (8-K), 10-Q filed |
| 29 Aug 2025 | 15.45% | 13.34 | |
| 15 Sep 2025 | 15.50% | 10.83 | |
| 30 Sep 2025 | 14.88% | 11.57 | |
| 15 Oct 2025 | 15.01% | 15.41 | |
| 31 Oct 2025 | 14.85% | 14.23 | |
| 14 Nov 2025 | 15.89% | 10.42 | results (8-K), 10-Q filed |
| 28 Nov 2025 | 15.81% | 13.49 | |
| 15 Dec 2025 | 15.82% | 17.56 | |
| 31 Dec 2025 | 16.11% | 18.26 |
See also: TG THERAPEUTICS, INC.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.